Skip to main content
. 2015 Jan 20;48(3):207–213. doi: 10.1590/1414-431X20144051

Figure 2. Immune-phenotypic analysis through flow cytometry detection. A, C, myelodysplastic syndromes (MDS) group; B, D, normal control group.

Figure 2